6 made to prevent any participants from accessing such information independently, or from 153 leaflets if these were part of standard care. the responses to the EQ-5D.
218
Mean costs for both intervention and control groups were compared using unpaired t tests between the randomised groups at entry in either trial ( (Table 3) . Adjusting for minimisation factors or performing 279 a 'treatment received' analysis did not change these results (Table 3) .
281
In both trials, there were no statistically significant differences in the prevalence of UI or the 10 continence occurred within three months of trial entry ( Figure 3 ). There was no evidence of 285 a difference between trial groups in effect on faecal incontinence or erectile function (data 286 not shown), or in any of the pre-specified subgroups ( Figure 4 ).
288
Economic evaluation after radical prostatectomy (Trial 1)
289
The UK NHS provides universal health care coverage with care free at the point of use 
301
On average, the QALYs were lower for the intervention although not statistically significantly 302 (-0.00003 [95% CI -0.026 to 0.026]). On average the intervention was dominated because it 303 was more costly and there was no evidence that it was any more effective.
305
Adverse effects
306
No adverse effects were reported by any participant in the trials.
308
Overall incontinence rates 309 At six weeks after radical prostatectomy, 59% (429/742) of men reported incontinence 310 ( Figure 1a ). Amongst the 411 randomised incontinent men, the rate of incontinence a year 311 later, irrespective of management and assuming non-responders were dry, was 73% (299 312 men incontinent, Table 2 ). Of the original total population of 742 men, this translates to 40%
313
(299) with any incontinence a year after radical prostatectomy (20% (152) severe, 18% (131) 314 wearing pads). As expected, the incontinence rate at trial entry six weeks following TURP 315 was lower (17%: 442/2590, Figure 1b ), but of the 442 randomised men, 57% (251) were still 316 wet 12 months later ( Table 2 ). Of the original total population of 2590 men, this translates to
Summary of main findings
continence rates or quality of life. It was significantly more costly to the NHS. Hence, 12 dropout from the randomised groups (Figures 1a and b ), and incontinence rates remained 360 similar even if the men lost to follow up were all assumed to be dry. This provided 361 reassurance that the outcome data were representative of the men included in the trials, and 362 that bias from differential attrition was minimal. We chose not to use objective measures of 363 incontinence, such as pad tests, because of practical difficulties but, more importantly, 364 because we felt that the men's rating of their incontinence was the more important clinical 365 outcome. (22) The data entry was by clerks blinded to randomisation thus minimising 366 detection bias. It was not possible to blind men or therapists to trial allocation. Performance
367
of PFMT was reported by the men themselves in questionnaires, and thus may have been 368 biased if they over-reported how many times they were expected to perform them rather 369 than their actual practice. This information could not be verified objectively but was only 370 used as a measure of the effect of attendance at therapy sessions on changing behaviour.
372
It is important to note that MAPS has not tested whether PFMT itself is an effective and 373 efficient way of reducing incontinence in men. In the current health care system where 374 information about incontinence after prostatectomy and PFMT is freely available, it would not 375 be possible to identify a control group which was unaware of pelvic floor exercises.
377
The methods of the economic analysis were rigorous and reproducible. Although not 378 reported in full here, we assessed the importance of uncertainties surrounding estimates of 379 costs, effects and cost-effectiveness, and the conclusions were robust to these. 
394
The frequency of delivery of the intervention (four times in three months combined with 395 home exercises) is typical of standard care in the NHS, and most men attended for the of contact with therapists after surgery, ranging from five sessions over 16 weeks (23) , to three times a week for three weeks (24) , to weekly as long as the incontinence persisted incontinence outcomes.(9) However, the aim of therapy in all trials is to teach and motivate 401 the men to perform pelvic floor exercises every day: MAPS showed that this was successful 402 in both trials (128/191, 67% performing them in Trial 1, and 122/188, 65% in Trial 2, 403 compared with 95/189, 50% and 39/193, 20% in the respective control groups, Table 2 ).
404
The timing of the intervention (starting six weeks postoperatively) was dictated by the terms 405 of the HTA commissioning brief, but it could be argued that starting earlier or before surgery 406 would result in unnecessary treatment of men who would become dry spontaneously.
408
Before randomisation, there were considerably fewer men in the control group in the TURP 409 trial performing PFMT compared to amongst the men after radical prostatectomy. This 
415
group were four times more likely to be actually performing PFMT before randomisation.
416
The type of incontinence may also have affected the chance of men performing PFMT: this 417 is recommended for stress urinary incontinence but men after TURP were more likely to 418 have urgency urinary incontinence (Table 1) . However, interestingly, the men in the 419 intervention groups in both trials were equally likely to report that they were still performing 420 PFMT at 12 months (around 65%).
422
We have only limited information about putative mechanisms for any effects of the 423 intervention through men's reports of performing exercises and their daily frequency.
424
Although we did see differential effects on these, the intervention might also be expected to 425 have wider effects, such as improving the quality rather than the quantity of pelvic floor 426 muscle contractions, the use of broader behavioural techniques such as BT, and generic 427 quality of life, which were not measured directly.
428
The incontinence rates extrapolated to the original populations of men having prostatectomy 429 (20% severe after radical prostatectomy and 10% after TURP) concur with those reported in one-to-one conservative therapy for men with UI after radical prostatectomy or TURP is 436 unlikely to be effective or cost-effective. Resources currently allocated to providing such a 437 service might be better used elsewhere.
439
Research is needed to identify the best management for the large numbers of men who are 440 left with persistent severe incontinence after radical prostatectomy, particularly the place of 441 continence surgery for men. Similarly, research is needed to identify the best management 442 for men with persistent incontinence following TURP.
interpretation of the study, 
EQ-5D
Mean ( Overall effect = 0.98, 95% CI [0.88 to 1.09], represented by broken line.
4b: Trial 2 TURP
Overall effect = 1.05, 95% CI [0.91 to 1.22], represented by broken line. Figure 4) :
Explanatory footnote (for
Leak Before = urinary incontinence before surgery Stress UI = stress urinary incontinence at randomisation after surgery Urge UI = urgency urinary incontinence at randomisation after surgery Mixed UI = both stress and urgency urinary incontinence after surgery PML = post-micturition leakage at randomisation after surgery
Other morbidity = participant with other health problems at randomisation Physiotherapist / Nurse = professional background of therapist delivering intervention
